LYSMD2 antibody

Principal name

LYSMD2 antibody

Alternative names for LYSMD2 antibody

LysM and putative peptidoglycan-binding domain-containing protein 2

SwissProt ID

Q1JQA8 (Bovin), Q3KPL3 (Xenla), Q8IV50 (Human), Q9D7V2 (Mouse)

Gene ID

256586 (LYSMD2)

Available reactivities

Hu (Human), Rt (Rat), Bov (Bovine), Chk (Chicken), Ms (Mouse), Ze (Zebrafish), GP (Guinea Pig), Por (Porcine), Rb (Rabbit)

Available hosts

Mouse, Rabbit

Available applications

ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)

Background of LYSMD2 antibody

Transient overexpression lysate of LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1

6 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

LYSMD2 antibody

  Rabbit polyclonal Anti-LYSMD2 Antibody  
WB Suggested Anti-LYSMD2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: HepG2 cell lysate Rabbit IgG Purified Bov, GP, Hu, Ms, Por, Rb, Ze WB
50 µg / €325.00
  OriGene Technologies, Inc.

Lysates

Catalog No.    

LYSMD2 overexpression lysate

LYSMD2 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, LYSMD2 (mGFP-tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, LYSMD2 (mGFP-tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, LYSMD2 (mGFP-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, LYSMD2 (mGFP-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, LYSMD2 (Myc-DDK tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, LYSMD2 (Myc-DDK tagged) - Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, LYSMD2 (Myc-DDK-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, LYSMD2 (Myc-DDK-tagged)-Human LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

6 Item(s)

per page
  • LinkedIn